166 related articles for article (PubMed ID: 37602699)
21. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts.
Hamamoto A; Abe Y; Nishi M; Fujimori S; Ohnishi Y; Yamazaki H; Oida Y; Miyazaki N; Inada K; Ueyama Y; Iwasaki M; Inoue H; Nakamura M
Int J Oncol; 2005 Apr; 26(4):891-6. PubMed ID: 15753982
[TBL] [Abstract][Full Text] [Related]
23. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
[TBL] [Abstract][Full Text] [Related]
24. CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma.
Slik K; Turkki R; Carpén O; Kurki S; Korkeila E; Sundström J; Pellinen T
Am J Surg Pathol; 2019 Nov; 43(11):1473-1482. PubMed ID: 31490234
[TBL] [Abstract][Full Text] [Related]
25. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract][Full Text] [Related]
27. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
[TBL] [Abstract][Full Text] [Related]
28. Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.
Barua RR; Uozaki H; Chong JM; Ushiku T; Hino R; Chang MS; Nagai H; Fukayama M
J Gastroenterol; 2006 Aug; 41(8):733-9. PubMed ID: 16988760
[TBL] [Abstract][Full Text] [Related]
29. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
Front Immunol; 2020; 11():621623. PubMed ID: 33613554
[TBL] [Abstract][Full Text] [Related]
30. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
31. CDX2 expression can predict response to neoadjuvant therapy in gastric carcinoma.
Fernández Aceñero MJ; Sánchez de Molina ML; Caso A; Vorwald P; Olmo DG; Palomar J; Estrada L; Díaz Del Arco C
Rom J Morphol Embryol; 2017; 58(4):1275-1278. PubMed ID: 29556617
[TBL] [Abstract][Full Text] [Related]
32. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
Domori K; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
[TBL] [Abstract][Full Text] [Related]
33. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
34. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
[TBL] [Abstract][Full Text] [Related]
35. Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.
Yamagishi H; Fukui H; Sekikawa A; Kono T; Fujii S; Ichikawa K; Tomita S; Imura J; Hiraishi H; Chiba T; Fujimori T
Mod Pathol; 2009 Jul; 22(7):906-13. PubMed ID: 19329938
[TBL] [Abstract][Full Text] [Related]
36. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa.
Barros R; Pereira D; Callé C; Camilo V; Cunha AI; David L; Almeida R; Dias-Pereira A; Chaves P
Dis Markers; 2016; 2016():1532791. PubMed ID: 27766003
[TBL] [Abstract][Full Text] [Related]
38. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
[TBL] [Abstract][Full Text] [Related]
39. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
